Autoimmune Intervention Mastery Course Study

Launched by TERRY L. WAHLS · Sep 15, 2021

Keywords

ClinConnect Summary

The Autoimmune Intervention Mastery Course Study is a clinical trial aimed at exploring whether an online program can help improve diet and self-care for patients dealing with certain health conditions. These conditions include multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, long COVID (which is when symptoms linger after a COVID-19 infection), and cancer survivors who are still feeling tired. The trial is currently looking for participants aged between 18 and 74 years, regardless of gender.

To be eligible, participants should have a self-reported diagnosis of one of the following: multiple sclerosis, clinically isolated syndrome, or long COVID with ongoing fatigue and mental health symptoms for over six months after a COVID-19 diagnosis. They can also join if they have fibromyalgia confirmed by a healthcare provider. If you join this study, you can expect to participate in the online program and share your experiences, which will help researchers understand its effectiveness. This is an exciting opportunity to contribute to valuable research that may improve the lives of others facing similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • self-reported multiple sclerosis
• • self-reported clinically isolated syndrome
• • OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,
• • OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,
• Exclusion Criteria:
• • -